- Report
- November 2023
- 160 Pages
Global
From €3435EUR$3,599USD£2,878GBP
- Report
- June 2023
- 120 Pages
Asia Pacific
From €3692EUR$3,869USD£3,094GBP
- Report
- March 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- March 2023
- 147 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- September 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2024
- 80 Pages
France
From €3340EUR$3,500USD£2,799GBP
- Report
- August 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- October 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 182 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- October 2023
- 177 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 70 Pages
Brazil
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 181 Pages
Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 176 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 160 Pages
Africa, Middle East
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 90 Pages
Middle East, Africa
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 90 Pages
Europe
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Latin America
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
United States
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Spain
From €4533EUR$4,750USD£3,798GBP
- Report
- February 2024
- 70 Pages
Vietnam
From €4533EUR$4,750USD£3,798GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more